JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stolk, J. M.
Right arrow Articles by Freedman, D. X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolk, J. M.
Right arrow Articles by Freedman, D. X.
Journal of Pharmacology And Experimental Therapeutics, Vol. 189, Issue 1, 42-50, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN NOREPINEPHRINE METABOLISM

Jon M. Stolk 1, Jack D. Barchas 1, Michael Goldstein 1, William Boggan 1, and Daniel X. Freedman 1

1 Department of Psychiatry, Stanford Medical Center, Stanford, California and University of Chicago School of Medicine, Chicago, Illinois

The effects of LSD, psilocybin, mescaline, amphetamine and cold water swimming stress on the metabolism of 3H-norepinephrine in rat brain were determined. Graded doses (130-1300 µg/kg) of LSD showed no specific effects on brain catecholamine metabolism, suggesting that this drug had little direct activity on brain noradrenergic neurons. Psilocybin (25 mg/kg) had effects similar to those obtained with amphetamine (2 mg/ kg), as evidenced by a prominent and sustained elevation in 3H-normetanephrine content. These findings are consistent with an increased release of norepinephrine from central nerve endings. Cold water swim stress, on the other hand, resulted in a profound increase in 3H-deaminated catechol metabolites, suggesting that the intracellular catabolism of norepinephrine was affected specifically. Mescaline (25 mg/kg) had a biphasic effect on brain 3H-norepinephrine metabolism. Shortly after injection, mescaline-treated rats imad a metabolite pattern similar to animals subjected to cold water swimming; from 90 minutes to 4 hours after mescaline, however, 3H-normetanephrine levels were elevated markedly. Based on these data, mescaline appears to cause an initial increase in intracellular 3H-norepinephrine metabolism, followed by a period of enhanced release similar to the effects of amphetamine and psilocybin. These data indicate that the psychotomimetic drugs tested share no single common effect on brain norepinephrine metabolism.

Submitted on February 19, 1973
Accepted on November 22, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.